C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim)
Time frame: 1 December 2022 - 30 November 2023Article ‘Count’ and ‘Share’ for C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim) based on listed parameters only.
The articles listed below published by authors from C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim), organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
| Journal | Count | Share |
|---|---|---|
|
Annals of the Rheumatic Diseases |
1 | 0.16 |
|
Cell |
2 | 0.43 |
|
Chemical Communications |
1 | 0.06 |
|
Chemical Science |
2 | 0.78 |
|
Circulation |
3 | 0.22 |
|
Clinical Infectious Diseases |
1 | 0.04 |
|
European Heart Journal |
1 | 0.11 |
|
Gut |
1 | 0.04 |
|
International Journal of Obesity |
1 | 0.10 |
|
JAMA: The Journal of the American Medical Association |
1 | 0.10 |
|
Journal of Cell Biology |
1 | 0.72 |
|
Journal of the American Academy of Dermatology |
1 | 0.27 |
|
Journal of the American College of Cardiology |
1 | 0.13 |
|
Nature |
4 | 0.63 |
|
Nature Biotechnology |
1 | 0.03 |
|
Nature Chemical Biology |
1 | 0.09 |
|
Nature Communications |
10 | 1.46 |
|
Nature Medicine |
1 | 0.07 |
|
Nature Photonics |
1 | 0.03 |
|
Organic Letters |
1 | 0.75 |
|
Proceedings of the National Academy of Sciences of the United States of America |
1 | 0.08 |
|
Science Advances |
1 | 0.33 |
|
The EMBO Journal |
1 | 0.18 |
|
The Lancet |
1 | 0.14 |
|
The Lancet Diabetes & Endocrinology |
1 | 0.25 |
|
Thorax |
1 | 0.40 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.